Efficacy of anti-CTLA-4 after progression on anti-PD1 therapy in advanced melanoma

被引：0
|
作者：
Aya Moreno, F. [1 ]
Fernandez-Martinez, A. [1 ]
Gaba, L. [1 ]
Victoria, I. [1 ]
Arance Fernandez, A. M. [1 ]
机构：
[1] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15P
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [1] Drug therapy of melanoma: anti-CTLA-4 and anti-PD-1 antibodies
    Robert, Caroline
    Mateus, Christina
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2014, 198 (02): : 297 - 308
  • [2] Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic Melanoma
    Reddy, Swathi B.
    Possick, Jennifer D.
    Kluger, Harriet M.
    Galan, Anjela
    Han, Dale
    [J]. JOURNAL OF IMMUNOTHERAPY, 2017, 40 (08) : 307 - 311
  • [3] Immunomodulating antibodies in the treatment of metastatic melanoma: The experience with anti-CTLA-4, anti-CD137, and anti-PD1
    Simeone, Ester
    Ascierto, Paolo A.
    [J]. JOURNAL OF IMMUNOTOXICOLOGY, 2012, 9 (03) : 241 - 247
  • [4] Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone
    Afzal, Muhammad Zubair
    Mabaera, Rodwell
    Shirai, Keisuke
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [5] Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy
    Bowyer, S.
    Prithviraj, P.
    Lorigan, P.
    Larkin, J.
    McArthur, G.
    Atkinson, V.
    Millward, M.
    Khou, M.
    Diem, S.
    Ramanujam, S.
    Kong, B.
    Liniker, E.
    Guminski, A.
    Parente, P.
    Andrews, M. C.
    Parakh, S.
    Cebon, J.
    Long, G. V.
    Carlino, M. S.
    Klein, O.
    [J]. BRITISH JOURNAL OF CANCER, 2016, 114 (10) : 1084 - 1089
  • [6] Effect of radiofrequency ablation (RFA) combined with anti-CTLA-4 and anti-PD1 in a preclinical melanoma model.
    Franco-Mahecha, Olga L.
    Christou, Anna
    Mauda-Havakuk, Michal
    Katti, Prateek
    Pritchard, William F.
    Karanian, John W.
    Wood, Bradford J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [7] Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy
    S Bowyer
    P Prithviraj
    P Lorigan
    J Larkin
    G McArthur
    V Atkinson
    M Millward
    M Khou
    S Diem
    S Ramanujam
    B Kong
    E Liniker
    A Guminski
    P Parente
    M C Andrews
    S Parakh
    J Cebon
    G V Long
    M S Carlino
    O Klein
    [J]. British Journal of Cancer, 2016, 114 : 1084 - 1089
  • [8] Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma
    Campbell, Katie M.
    Amouzgar, Meelad
    Pfeiffer, Shannon M.
    Howes, Timothy R.
    Medina, Egmidio
    Travers, Michael
    Steiner, Gabriela
    Weber, Jeffrey S.
    Wolchok, Jedd D.
    Larkin, James
    Hodi, F. Stephen
    Boffo, Silvia
    Salvador, Lisa
    Tenney, Daniel
    Tang, Tracy
    Thompson, Marshall A.
    Spencer, Christine N.
    Wells, Daniel K.
    Ribas, Antoni
    [J]. CANCER CELL, 2023, 41 (04) : 791 - +
  • [9] Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases
    da Silva, Ines Pires
    Li, Isabel
    Ugurel, Selma
    Serra-Bellver, Patricio
    Andhale, Avanti
    Burnette, Hannah
    Aya, Francisco
    Conway, Jordan W.
    Braden, Jorja
    Carlino, Matteo S.
    Menzies, Alexander M.
    Weichenthal, Michael
    Mohr, Peter
    Gutzmer, Ralf
    Arance, Ana M.
    Johnson, Douglas B.
    Lorigan, Paul
    Schadendorf, Dirk
    Lo, Serigne N.
    Long, Georgina V.
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 205
  • [10] Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy'
    Imafuku, Keisuke
    Yoshino, Koji
    Yamaguchi, Kei
    Tsuboi, Satoshi
    Ohara, Kuniaki
    Hata, Hiroo
    [J]. BRITISH JOURNAL OF CANCER, 2017, 116 (08) : e14 - e14
12345